Literature DB >> 18662671

ARHGAP21 associates with FAK and PKCzeta and is redistributed after cardiac pressure overload.

Luciene Borges1, Carolina Louzão Bigarella, Mariana Ozello Baratti, Daniella P Crosara-Alberto, Paulo P Joazeiro, Kleber G Franchini, Fernando F Costa, Sara Teresinha Olalla Saad.   

Abstract

ARHGAP21 is highly expressed in the heart, which demonstrates activity over Cdc42 and interacts with proteins of the cytoskeleton and adherent junctions. The main cause of cardiac hypertrophy is mechanical stimulus; therefore we analyzed ARHGAP21 expression after acute mechanical stress in the myocardium and its association with FAK and PKCzeta. We demonstrated that ARHGAP21 is relocated to Z-lines and costameres after pressure overload, and interacts with PKCzeta and FAK in control rats (sham), rats submitted to aortic clamping and spontaneously hypertensive rats (SHR). Co-transfection using ARHGAP21 and PKCzeta constructions demonstrated that ARHGAP21 associates with PKCzeta-GST and endogenous FAK. Pulldown assay showed that ARHGAP21 binds to the C-terminal region of FAK. Moreover, ARHGAP21 binds to PKCzeta phosphorylated on Thr410 in sham and SHR. However, ARHGAP21 only binds to FAK phosphorylated on Tyr925 of SHR. Additionally, PKCzeta is phosphorylated by mechanical stimuli. These results suggest that ARHGAP21 may act as a signaling or scaffold protein of FAK and PKCzeta signaling pathways, developing an important function during cardiac stress.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18662671     DOI: 10.1016/j.bbrc.2008.07.085

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  7 in total

1.  Sirtuin 1 represses PKC-ζ activity through regulating interplay of acetylation and phosphorylation in cardiac hypertrophy.

Authors:  Jingyan Li; Junying Huang; Jing Lu; Zhen Guo; Zhuoming Li; Hui Gao; Panxia Wang; Wenwei Luo; Sidong Cai; Yuehuai Hu; Kaiteng Guo; Luping Wang; Zhenzhen Li; Minghui Wang; Xiaolei Zhang; Peiqing Liu
Journal:  Br J Pharmacol       Date:  2018-12-09       Impact factor: 8.739

2.  β-Arrestin 1 inhibits the GTPase-activating protein function of ARHGAP21, promoting activation of RhoA following angiotensin II type 1A receptor stimulation.

Authors:  D F Anthony; Y Y Sin; S Vadrevu; N Advant; J P Day; A M Byrne; M J Lynch; G Milligan; M D Houslay; G S Baillie
Journal:  Mol Cell Biol       Date:  2010-12-20       Impact factor: 4.272

3.  Protein kinase C (PKC)ζ-mediated Gαq stimulation of ERK5 protein pathway in cardiomyocytes and cardiac fibroblasts.

Authors:  Carlota García-Hoz; Guzmán Sánchez-Fernández; Ramón García-Escudero; María Fernández-Velasco; Julia Palacios-García; Marisol Ruiz-Meana; Maria Teresa Díaz-Meco; Michael Leitges; Jorge Moscat; David García-Dorado; Lisardo Boscá; Federico Mayor; Catalina Ribas
Journal:  J Biol Chem       Date:  2012-01-09       Impact factor: 5.157

4.  ARHGAP10, downregulated in ovarian cancer, suppresses tumorigenicity of ovarian cancer cells.

Authors:  N Luo; J Guo; L Chen; W Yang; X Qu; Z Cheng
Journal:  Cell Death Dis       Date:  2016-03-24       Impact factor: 8.469

5.  The roles of ARHGAP10 in the proliferation, migration and invasion of lung cancer cells.

Authors:  Ji-Ping Teng; Zhi-Ying Yang; Yu-Ming Zhu; Da Ni; Zhi-Jun Zhu; Xiao-Qiang Li
Journal:  Oncol Lett       Date:  2017-08-07       Impact factor: 2.967

Review 6.  ErbB/integrin signaling interactions in regulation of myocardial cell-cell and cell-matrix interactions.

Authors:  Laura Pentassuglia; Douglas B Sawyer
Journal:  Biochim Biophys Acta       Date:  2012-12-20

7.  miR-3174 Contributes to Apoptosis and Autophagic Cell Death Defects in Gastric Cancer Cells by Targeting ARHGAP10.

Authors:  Bowen Li; Lu Wang; Zheng Li; Weizhi Wang; Xiaofei Zhi; Xiaoxu Huang; Qiang Zhang; Zheng Chen; Xuan Zhang; Zhongyuan He; Jianghao Xu; Lu Zhang; Hao Xu; Diancai Zhang; Zekuan Xu
Journal:  Mol Ther Nucleic Acids       Date:  2017-10-17       Impact factor: 8.886

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.